WATCH: COVID-19 and aging adults

Parminder Raina, scientific director of the McMaster Institute for Research on Aging, explains a new nationwide study that will investigate the spread and impact of COVID-19 on older adults.

October 2, 2020

A scientist wearing full protective lab gear, including gloves, face shield, mask and gown, is carefully holding something with smoke or mist coming off it.
A new nationwide study will investigate the spread and impact of COVID-19 on older adults.

Expert Featured In This Story

Parminder Raina
Parminder Raina

Professor

See Profile

Parminder Raina, a professor in the Department of Health Research Methods, Evidence, and Impact at McMaster and the scientific director of the McMaster Institute for Research on Aging, explains how a national study involving 19,000 Canadians will examine blood samples and responses to a questionnaire to investigate the spread and impact of COVID-19 among aging Canadians.

“In basic terms, the blood sample analysis will show how widespread SARS-CoV-2 infection is among men and women over age 50, while the questionnaire will tell us about the lives of those individuals since the onset of the pandemic.”

A couple walking on a path, one of them using a walker for assistance.

McMaster researchers identify genetic factors linked to frailty

Understanding what influences frailty opens the door to earlier screening and personalized approaches to supporting healthy aging, researchers say
A close-up of a vial containing a clear peptide blend of BPC-157 and TB-500, next to two single-use syringes.

What do we know about ‘research only’ peptides? Q&A with expert Stuart Phillips 

Unapproved peptides that lack safety and efficacy data carry substantial risks and belong in a laboratory, not your body, Phillips warns.
Scientist Jon Stokes stands in a university corridor, wearing a hoodie and ball cap.

McMaster researcher awarded more than $2M from Weston Family Foundation to advance precision antibiotic for IBD

The funding will accelerate the move toward human trials, enabling preclinical studies, regulatory preparation and early-phase clinical trial design.